Brelovitug (BJT-778)
BJT-778-303
Phase 3 small_molecule active
Quick answer
Brelovitug (BJT-778) for Chronic Hepatitis D is a Phase 3 program (small_molecule) at Mirum Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Chronic Hepatitis D
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active